Target intelligence / Profile preview

MT-ND2 pseudogene 28 (MTND2P28)

Target
MTND2P28
Molecular classification
Pseudogene
01

Overview

MT-ND2 pseudogene 28 (MTND2P28) is a pseudogene homologous to MT-ND2, a core subunit of mitochondrial respiratory chain Complex I. Unlike the functional MT-ND2 gene, this pseudogene is not predicted to encode a functional protein and does not participate directly in electron transport or oxidative phosphorylation. Pseudogenes are non-functional segments of DNA resembling functional genes. MTND2P28 is distinguished from the protein-coding MT-ND2 gene, which encodes a subunit of mitochondrial Complex I and is involved in mitochondrial energy production and disease. Recent transcriptomic analyses have observed MTND2P28 as one of several pseudogenes that show differential expression in various tissues, notably being significantly downregulated in certain brain regions in Alzheimer’s disease cases compared to controls. The pseudogene’s precise regulatory or biological function, if any, remains unclear, but differential tissue expression patterns suggest possible use as a biomarker in research settings, especially for neurodegenerative disease. There is no current evidence linking MTND2P28 to drug interactions, protein function, or classical therapeutic target roles. No evidence supports MTND2P28 as a receptor, enzyme, transporter, or drug target.

Other names
MTND2P28mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 28
02

Disease associations

Biomarker in neurodegenerative disease studies (e.g., Alzheimer’s disease)
03

Biomarkers

Downregulation in certain brain tissues of Alzheimer’s disease patients (potential biomarker for tissue-specific neurodegenerative processes)

Beyond the preview

Go deeper on MT-ND2 pseudogene 28 (MTND2P28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND2 pseudogene 28 (MTND2P28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call